Skip to content

LEXARIA BIOSCIENCE CORP.: 10-Q filed 2016-07-13

What LEXARIA BIOSCIENCE CORP. reported in its quarterly report filed 2016-07-13 (fiscal Q3 2016): 30 published measures, 81 facts as tagged in accession 0001062993-16-010536.

This filing

Form
10-Q (quarterly report)
Filed
2016-07-13
Fiscal period
fiscal Q3 2016
Accession
0001062993-16-010536 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All LEXARIA BIOSCIENCE CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2016-05-31331,251USD
At 2015-08-31711,722USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2016-05-31376,536USD
At 2015-08-3155,125USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2016-05-31120,690USD
At 2015-08-31772,409USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2016-05-3137,102USD
At 2015-08-31260,075USD
At 2015-05-31832,101USD
At 2014-08-31703,030USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2015-09-01 to 2016-05-31-400,089USD274
2014-09-01 to 2015-05-31-920,138USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2015-09-01 to 2016-05-313,094USD274
2014-09-01 to 2015-05-310USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2015-09-01 to 2016-05-31192,480USD274
2014-09-01 to 2015-05-31368,358USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2015-09-01 to 2016-05-31-15,364USD274
2014-09-01 to 2015-05-31680,851USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2016-05-31-10,986,229USD
At 2015-08-31-10,085,889USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2016-05-312,630USD
At 2015-08-310USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2016-03-01 to 2016-05-3142,305USD92
2015-09-01 to 2016-05-3180,253USD274
2015-03-01 to 2015-05-3168,061USD92
2014-09-01 to 2015-05-31242,781USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2016-03-01 to 2016-05-31-264,201USD92
2015-09-01 to 2016-05-31-950,503USD274
2015-03-01 to 2015-05-31-511,008USD92
2014-09-01 to 2015-05-31-1,367,688USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2016-05-31279,362USD
At 2015-08-31674,733USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2016-03-01 to 2016-05-311,047USD92
2015-09-01 to 2016-05-311,125USD274
2015-03-01 to 2015-05-310USD92
2014-09-01 to 2015-05-3131,544USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2016-05-31331,536USD
At 2015-08-3155,125USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2016-05-3114,569USD
At 2015-08-3131,382USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2016-03-01 to 2016-05-31261,107USD92
2015-09-01 to 2016-05-31939,730USD274
2015-03-01 to 2015-05-31508,504USD92
2014-09-01 to 2015-05-311,366,015USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2016-05-31126,774USD
At 2015-08-31167,986USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2016-03-01 to 2016-05-31-3,094USD92
2015-09-01 to 2016-05-31-10,773USD274
2015-03-01 to 2015-05-31-2,504USD92
2014-09-01 to 2015-05-31-1,673USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2016-03-01 to 2016-05-31158USD92
2015-09-01 to 2016-05-318,987USD274
2015-03-01 to 2015-05-31107USD92
2014-09-01 to 2015-05-3148,386USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2016-05-3145,513,282shares
At 2015-08-3139,852,984shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2016-05-3111,061,407USD
At 2015-08-3110,818,446USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2016-05-31-45,285USD
At 2015-08-31656,597USD
At 2014-08-311,717,098USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2016-05-31100,917USD
At 2015-08-31215,290USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2015-09-01 to 2016-05-31-900,340USD274
2014-09-01 to 2015-08-31-1,770,500USD365

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2016-03-01 to 2016-05-31-258,028USD92
2015-09-01 to 2016-05-31-900,340USD274
2015-03-01 to 2015-05-31-467,506USD92
2014-09-01 to 2015-05-31-1,254,670USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2016-03-01 to 2016-05-312,047USD92
2015-09-01 to 2016-05-3110,706USD274
2015-03-01 to 2015-05-318,735USD92
2014-09-01 to 2015-05-3119,785USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2016-03-01 to 2016-05-31464USD92
2015-09-01 to 2016-05-31464USD274
2015-03-01 to 2015-05-310USD92
2014-09-01 to 2015-05-310USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2015-09-01 to 2016-05-31-16,813USD274
2014-09-01 to 2015-05-31-75,371USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2015-09-01 to 2016-05-31-714USD274
2014-09-01 to 2015-05-3179,344USD273

Inspect the source

Entity
LEXARIA BIOSCIENCE CORP. / CIK 0001348362
Captured
2026-09-20T07:55:03.045Z
SEC response SHA-256
c8696dbfbdb8ee1a7522ea5b45a8c2d45cb12720b3d84857c1cda6bba2861389

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001348362.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))